| Financial Year |
March 31 2023 |
| Monetary Funds |
153,225,997.09 |
| Held-for-trading Financial Assets |
20,020,000.00 |
| Notes Receivable |
28,065,273.98 |
| Accounts Receivable |
128,758,428.76 |
| Advances to Suppliers |
2,892,666.28 |
| Other Receivables |
435,155.11 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
155,945,031.86 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,334,186.87 |
| Total Current Assets |
512,822,055.92 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
737,254,541.48 |
| Under-construction Projects |
11,707,055.25 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
36,132,561.95 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
183,486.23 |
| Deferred Income Tax Assets |
4,417,441.54 |
| Other Non-Current Assets |
1,582,439.00 |
| Sub-Total of Non-Current Assets |
791,629,984.23 |
| Total Assets |
1,304,452,040.15 |
| Short-Term Loans |
76,186,173.63 |
| Trading Financial liabilities |
-- |
| Notes Payable |
5,000,000.00 |
| Accounts Payable |
101,253,802.81 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
5,563,143.13 |
| Taxes Payable |
1,846,933.31 |
| Interest Payable |
-- |
| Dividend Payable |
5,720.00 |
| Other payables |
9,213.00 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
21,361,670.78 |
| Other Current Liabilities |
14,329,031.71 |
| Sub-Total of Current Liabilities |
226,241,841.68 |
| Long-term Loans |
16,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
32,830,638.98 |
| Total Liabilities |
259,072,480.66 |
| Paid-In Capital(Or Share Stock) |
281,066,667.00 |
| Capital Surplus |
527,221,173.55 |
| Surplus Reserve |
52,532,716.13 |
| LESS:Treasury Stock |
101,392,750.20 |
| Undistributed Profits |
285,951,753.01 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,045,379,559.49 |
| Owner's Equity（Stockholder's Equity） |
1,045,379,559.49 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,304,452,040.15 |
